stockrow
Saturday 7 November 2026
Export DMRA’s income statement to Excel — free account
Galecto, Inc.
DMRA Healthcare Biotechnology
- EPS
- +78.1%
- Free cash flow
- −877.5%
Quarter to September 2026, against a year earlier
23.67
1.81
+8.28%
Follow DMRA
Alert me
| Older periods | Dec '25 | Mar '26 | Jun '26 | Sep '26 | |
|---|---|---|---|---|---|
Current Ratio |
+8 more quarters Free account |
12.98 | 22.48 | 19.73 | 14.80 |
Net Debt/EBITDA |
1.28 | 17.30 | 15.45 | 14.23 | |
Debt/Assets |
0.00% | 0.00% | 0.00% | 0.00% | |
Debt/Equity |
0.00 | 0.00 | 0.00 | 0.00 | |
Asset Turnover |
0.00 | 0.00 | 0.00 | 0.00 | |
Operating CF/Net income |
0.15 | 0.97 | 0.70 | 0.70 | |
Capex/Depreciation |
0.00 | 0.00 | 0.00 | 0.00 | |
Research and Development Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Selling, General and Administrative Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Intangible Assets out of Total Assets |
0.00 | 0.00 | 0.00 | 0.00 | |
Share Based Compensation of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Free Cash Flow per Share |
0.42 | (0.60) | (0.36) | (0.28) | |
Cash per Share |
189.01 | 15.54 | 8.84 | 8.55 | |
Shareholders Equity per Share |
176.36 | 14.92 | 8.44 | 8.02 | |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Book value per Share |
176.36 | 14.92 | 8.44 | 8.02 | |
Free Cash Flow |
0.57 | (20.60) | (21.87) | (17.23) | |
Working Capital |
240.36 | 511.60 | 516.04 | 495.43 | |
Net Current Asset Value |
240.28 | 511.57 | 516.01 | 494.45 | |
| Other line items | |||||
Quick Ratio |
12.84 | 22.38 | 19.62 | 14.72 | |
Revenue per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Operating CF per Share |
0.42 | (0.60) | (0.36) | (0.28) | |
Capex per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Average Payables |
9.02 | 6.59 | 4.95 | 5.78 | |
Average Assets |
138.83 | 275.40 | 278.66 | 271.68 | |
Average Common Equity |
(80.70) | 195.75 | 197.84 | 186.22 |
Columns are period end dates · fundamentals updated 6 Nov 2026